Study finds potential to match tumors with known cancer drugs
from Medical Xpress
When it comes to gene sequencing and personalized medicine for cancer, spotting an aberrant kinase is a home run. The proteins are relatively easy to target with drugs and plenty of kinase inhibitors already exist. In a new study, University of Michigan Comprehensive Cancer Center researchers assess the complete landscape of a cancer's "kinome" expression and determine which kinases are acting up in a particular tumor. They go on to show that those particular kinases can be targeted with drugs — potentially combining multiple drugs to target multiple kinases.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063